Thrombotic thrombocytopenic purpura

Moschcowitz, 1924, Hyaline thrombosis of the terminal arterioles and capillaries: a hitherto undescribed disease, Proc N Y Pathol Soc, 24, 21 Amorosi, 1966, Thrombotic thrombocytopenic purpura: report of 16 cases and review of the literature, Medicine (Baltimore), 45, 139, 10.1097/00005792-196603000-00003 Burke, 1959, Thrombotic thrombocytopenic purpura; two patients with remission associated with the use of large amounts of steroids, Arch Intern Med, 103, 105, 10.1001/archinte.1959.00270010111014 Rubinstein, 1959, Unusual remission in a case of thrombotic thrombocytopenic purpura syndrome following fresh blood exchange transfusions, Ann Intern Med, 51, 1409, 10.7326/0003-4819-51-6-1409 Byrnes, 1977, Treatment of thrombotic thrombocytopenic purpura with plasma, N Engl J Med, 297, 1386, 10.1056/NEJM197712222972507 Moake, 1982, Unusually large plasma factor VIII: von Willebrand factor multimers in chronic relapsing thrombotic thrombocytopenic purpura, N Engl J Med, 307, 1432, 10.1056/NEJM198212023072306 Furlan, 1977, Deficient activity of von Willebrand factor-cleaving protease inchronic relapsing thrombotic thrombocytopenic purpura, Blood, 89, 3097, 10.1182/blood.V89.9.3097 Fujikawa, 2001, Purification of human von Willebrand factor-cleaving protease and its identification as a new member of the metalloproteinase family, Blood, 98, 1662, 10.1182/blood.V98.6.1662 Vesely, 2003, ADAMTS13 activity in thrombotic throm-bocytopenic purpura-hemolytic uremic syndrome: relation to presenting features and clinical outcomes in a prospective cohort of 142 patients, Blood, 102, 60, 10.1182/blood-2003-01-0193 Levy, 2001, Mutations in a member of the ADAMTS gene family cause thrombotic thrombocytopenic purpura, Nature, 413, 488, 10.1038/35097008 Tsai, 1988, Antibodies to von Wille-brand factor-cleaving protease in acute thrombotic thrombocytopenic purpura, N Engl J Med, 339, 1585, 10.1056/NEJM199811263392203 Pourrat, 2015, Differentiation between severe HELLP syndrome and thrombotic microangiopathy, thrombotic thrombocytopenic purpura and other imitators, Eur J Obstetr Gynecol Reprod Biol, 189, 68, 10.1016/j.ejogrb.2015.03.017 Kojouri, 2001, Quinine-associated thrombotic thrombocyto-penic purpura-hemolytic uremic syndrome: frequency, clinical features, and long-term outcomes, Ann Intern Med, 135, 1047, 10.7326/0003-4819-135-12-200112180-00008 Saste, 2007, Drug-Associated Thrombotic Thrombocytopenic Purpura-Hemolytic Uremic Syndrome (TTP-HUS): frequency. presenting features, and clinical outcomes, ASH Annu Meet Abst, 110, 1315 Sarkodee-Adoo, 2003, Thrombotic microangiopathy in blood and marrow transplant patients receiving tacrolimus or cyclosporine A, Transfusion, 43, 78, 10.1046/j.1537-2995.2003.00282.x Sarode, 1995, Therapeutic plasma exchange does not appear to be effective in the management of thrombotic thrombocytopenic purpura/hemolyti curemic syndrome following bone marrow transplantation, Bone Marrow Transplant, 16, 271 Terrell, 2005, The incidence of thrombotic thrombocytopenic purpura-hemolytic uremic syndrome: all patients, idiopathic patients, and patients with severe ADAMTS13 deficiency, J Thromb Haemost, 3, 1432, 10.1111/j.1538-7836.2005.01436.x Asada, 1985, Immunohistochemistry of vascular lesion in thrombotic thrombocytopenic purpura, with special reference to factor VIII related antigen, Thromb Res, 38, 469, 10.1016/0049-3848(85)90180-X Furlan, 1998, Von Willebrand factor-cleaving protease in thrombotic thrombocytopenic purpura and the hemolytic-uremic syndrome, N Engl J Med, 339, 1578, 10.1056/NEJM199811263392202 Neame, 1980, Immunologic and other factors in thrombotic thrombocytopenic purpura (TTP), Semin Thromb Hemost, 6, 416, 10.1055/s-2007-1005113 Wada, 1992, Plasma cytokine levels in thrombotic thrombocytopenic purpura, Am J Hematol, 40, 167, 10.1002/ajh.2830400303 Moake, 2002, Thrombotic microangiopathies, N Engl J Med, 347, 589, 10.1056/NEJMra020528 James, 2006, Thrombotic thrombocytopenic purpura, N Engl J Med, 354, 1927, 10.1056/NEJMcp053024 Ogborn, 1998, Renal function in Inuit survivors of epidemic hemolytic-uremic syndrome, Pediatr Nephrol, 12, 485, 10.1007/s004670050493 Hughes, 2009, Cardiac involvement in acute thrombotic thrombocytopenic purpura: association with troponin T and IgG antibodies to ADAMTS 13, J Thromb Haemost, 7, 529, 10.1111/j.1538-7836.2009.03285.x Hawkins, 2008, Clinical cardiac involvement in thrombotic thrombocytopenic purpura: a systematic review, Transfusion (Paris), 48, 382 Hovinga, 2010, Survival and relapse in patients with thrombotic thrombocytopenic purpura, Blood, 115, 1500, 10.1182/blood-2009-09-243790 Sperati, 2015, Thrombotic microangiopathy focus on atypical hemolytic uremic syndrome, Hematol Oncol Clin N Am, 29, 541, 10.1016/j.hoc.2015.02.002 Keiser, 2012, A high LDH to AST ratio helps to differentiate pregnancy-associated thrombotic thrombocytopenic purpura (TTP) from HELLP syndrome, J Matern Fetal Neonatal Med, 25, 1059, 10.3109/14767058.2011.619603 Scully, 2012, Guidelines on the diagnosis and management of thrombotic thrombocytopenic purpura and other thrombotic microangiopathies, Br J Haemat, 158, 323, 10.1111/j.1365-2141.2012.09167.x Rock, 1991, Comparison of plasma exchange with plasma infusion in the treatment of thrombotic thrombocytopenic purpura. Canadian Apheresis Study Group, N Eng J Med, 325, 393, 10.1056/NEJM199108083250604 Coppo, 2003, High-dose plasma infusion versus plasma exchange as early treatment of thrombotic thrombocytopenicpurpura/hemolytic-uremic syndrome, Medicine (Baltimore), 82, 27, 10.1097/00005792-200301000-00003 O'Shaughnessy, 2004, Guidelines for the use of fresh frozen plasma, cryoprecipitate and cryosupernatant, Br J Haematol, 126, 11, 10.1111/j.1365-2141.2004.04972.x Westwood, 2013, Rituximab for thrombotic thrombocytopenicpurpura: benefit of early administration during acute episodes and use of prophylaxis to prevent relapse, J Thromb Haemost, 11, 481, 10.1111/jth.12114 Lim, 2015, The role of rituximab in the management of patients with acquired thrombotic thrombocyto-penic purpura: evidence-based focused review, Blood, 125, 1526, 10.1182/blood-2014-10-559211 Hie, 2014, Preemptive rituximab infusions after remission efficiently prevent relapses in acquired thrombotic thrombocytopenic purpura, Blood, 124, 204, 10.1182/blood-2014-01-550244 Pequeño-Luévano, 2013, Low-dose Rituximab for the treatment of acute thrombotic thrombocytopenic purpura: report of four cases, Hematology, 18, 233, 10.1179/1607845412Y.0000000073 Plaimauer, 2011, Recombinant ADAMTS13 normalizes von Willebrand factor-cleaving activity in plasma of acquired TTP patients by overriding inhibitory antibodies, J Thromb Haemost, 9, 936, 10.1111/j.1538-7836.2011.04224.x Rock, 1991, Comparison of plasma exchange with plasma infusion in the treatment of thrombotic thrombocytopenic purpura, N Engl J Med, 325, 393, 10.1056/NEJM199108083250604 Defford, 2013, Multiple major morbidities and increased mortality during long-term follow-up after recovery from thrombotic thrombocytopenic purpura, Blood, 122, 2023, 10.1182/blood-2013-04-496752 Lewis, 2009, Long-term deficits inhealth-related quality of life after recovery from thrombotic thrombocytopenic purpura, Transfusion, 49, 118, 10.1111/j.1537-2995.2008.01938.x Kennedy, 2009, Cognitive deficits after recovery from thrombotic thrombocytopenic purpura, Transfusion (Paris), 49, 1092, 10.1111/j.1537-2995.2009.02101.x Shumak, 1995, Late relapses in patients successfully treated for thrombotic thrombocytopenic purpura, Ann Intern Med, 122, 569, 10.7326/0003-4819-122-8-199504150-00002 Kremer Hovinga, 2010, Survival and relapse in patients with thrombotic thrombocytopenic purpura, Blood, 115, 1500, 10.1182/blood-2009-09-243790